Indole-3-carbinol (I3C) modulates expression of DNA methyltransferases 1, 3a, and 3b in pancreatic cancer cells: Effects of gender and a novel (C → T) polymorphism in the promoter region of DNMT 3b

International Journal of Cancer Prevention

Volumn 2, Issue 4, 2007, Pages 245-255

  Haefele, Aaron ^a   Word, Beverly ^b   Yongmei, Xiao ^c   Hammons, George ^b   Lyn Cook, Beverly D ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c NONE

Author keywords

DNMTs; Gemcitabine; Indole 3 carbinol; Pancreatic cancer cells

Indexed keywords

3 INDOLEMETHANOL; CYTOSINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GEMCITABINE; THYMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROMOTER REGION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 34948907867     PISSN: 15541134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Jemal A, Thomas A., Murray T, Thun M (2002). Cancer statistics. CA - Cancer J Clin, 52: 23-47.
2. Bouvet M, Binmoeller KF, Moossa AR (2001). Diagnosis of adenocarcinoma of the pancreas. In: American Cancer Society Atlas of Clinical Oncology: Pancreatic Cancer. Cameron JL (ed), BC Decker, Hamilton, Ontario, Canada.
3. Gold, E (1995). Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am, 75(5): 819-43.
4. Pernick NL, Sarkar FH, Philip PA, Arlauskas P, Shields AF, Vaitkevicius VK, Dugan MC, Adsay NV (2003). Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas J, 26: 28-32.
5. Jones PA, Baylin SB (2002). The fundamental role of epigenetics events in cancer. Nat Rev Genet, 3: 415-428.
6. Laird P, Jaenisch R (1996). The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet, 30: 441-464.
7. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M. (2000). Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res, 60: 1835-1839.
8. Sato N, Maitra A, Fukushima N, et al. (2003). Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res, 63: 4158-4166.
9. Esteller M (2002). CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21: 5427-5440.
10. Bestor T, Laudano A, Mattaliano R, Ingram V (1988). Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol, 203: 971-983.
11. Okano M, Xie S, Li E (1998). Cloning and characterization of novel mammalian DNA (cytosine-5) ???missing line unreadable???
12. Bestor TH (2000). The DNA methyltransferases. Hum Mol Genet, 9:2395-2402.
13. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T (2001). Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J, 20: 2536-3544.
14. Bachmann K, Rountree MR, Baylin SB (2001). Dnmt3a and Dumt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem, 276: 32282-32287.
15. Rhee I, Bachman KE, Park BH, Jair K-W, Yen R-WC, Schuebel KE, Cul H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416: 552-556.
16. Liang G, Chan MF, Tomigahara Y, Tsai YC, Gonzales F, Li E, Laird PW, Jones PA (2002). Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol, 22: 480-491.
17. Belinsky SA, Nikula KJ, Baylin SB, Issa J-PJ (1996). Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA, 93: 4045-4050.
18. Melki JR, Warnecke P, Vincent PC, Clark SJ (1998). Increased DNA methyltransferase expression in leukaemia. Leukemia, 12: 311-316.
19. Girault I, Tozlu S, Lidereau R, Bieche I (2003). Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res, 9: 4415-4422.
20. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001). DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer, 91:205-212.
21. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA (1999). The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res, 27: 2292-2298.
22. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP (2001). DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Gynecologic Oncology, 82: 299-304.
23. Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S (1997). Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res., 88: 1165-1170.
24. Nagai M, Nakamura A, Makino R, Mitamura K (2003). Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res, 26: 186-191.
25. Wu J, Issa JP, Herman J, Bassett DE J., Nelkin BD, Baylin SB (1993). Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA, 90: 8891-8895.
26. Ramchandani S, MacLeod AR, Pinard M, von Hope E, Szyf, M (1997). Inhibition of tumorigenesis by a cytosine-DNA methyltransferase antisense oligodeoxynucleotide. Proc Natl Acad Sci USA, 94: 684-689.
27. Min/+ Dnmt1-hypomorphic mice. Cancer Res, 62: 1296-1299.
28. Belinsky SA, Klinge DM, Stidley CA, Issa J-P, Herman JG, March TH, Baylin SB (2003). Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res, 63: 7089-7003.
29. Peng D-F, Kanai Y, Sawada M, Ushijima S, Hiraoka N, Kosuge T, Hirohashi S (2005). Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Jpn Cancer Assoc, 96: 403-408.
30. Kopelovich L, Crowell JA, Fay JR (2003). The epigenome as a target for cancer chemoprevention. J Natl Cancer Instit, 95: 1747-1757.
31. Karpf AR, Jones DA (2003). Reactivating the expression of methylation silenced genes in human cancer. Oncogene, 21: 5496-5495.
32. Christman JK (2002). 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene, 21: 5483-5495.
33. Issa JP (2003). Decitabine. Curr Opin Oncol, 15: 446-451.
34. 161NK4α, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res, 11: 7033-7041.
35. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS (2003). Tea polyphenol (-)-epigallocatechin-3-gallate inhibitis DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res, 63: 7563-7570.
36. Lee WJ, Shim J-Y, Zhu BT (2005). Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol, 68: 1018-1030.
37. Ng S, Tsao M, Nicklee T, Hedley DW. (2001). Wortmannin Inhibits PKB/Akt Phosphorylation and Promotes Gemcitabine Antitumor Activity in Orthotopic Human Pancreatic Cancer Xenografts in Immunodicient Mice. Clin Cancer Res, 7: 3269-3275.
38. Akada M, Crnogorac-Jurcevic T, Latimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR (2005). with Decreased Expression of BNIP3 in Pancreatic Cancer. Clin Cancer Res, 11(8): 3094-3101.
39. Broadbent TA, Broadbent HS (1998). 1. The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part II]. Curr Med Chem, 5: 469-491.
40. Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA, van Poppel G (1997). A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact, 103, 79-129.
41. Bradlow HL, Michnovicz J, Telang NT, Osborne MP (1991). Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis, 12: 1571-1574.
42. Kojima T, Tanaka T, Mori H (1994). Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res, 54: 1446-1449.
43. Sharma S, Stutzman JD, Kelloff GJ, Steele VE (1994). Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res, 54: 5848-5855.
44. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA (2003). Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol, 41: 745-752.
45. Chen DZ, Qi M, Auborn KJ, Carter TH (2001). Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr, 131: 3294-3302.
46. Zhang X, Malejka-Giganti D (2003). Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas. Anticancer Res, 23: 2473-2479.
47. Lian JP, Word B, Taylor S, Hammons GJ, Lyn-Cook, BD (2004). Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res, 24: 133-138.
48. Wang L, Rodriguez M, Yue P, Sun SY, Hong WK, Mao L (2001). Polymorphism in DNMT3B6 promoter region and lung cancer risk. Proc Am Assoc Cancer Res, 42: 863.
49. Xie S, Wang Z, Okano M, Nogami M, Li Y, He W-W, Okumura K, Li E (1999). Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 236: 87-95.
50. Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW, Baker, SD, Zhao M, Weber JS (2003). Phase I trial of continous infusion 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol, 51: 231-239.
51. Rouleau J, MacLeod AR, Szyf M (1995). Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathway. J Biol Chem, 270: 1595-1601.
52. MacLeod AR, Rouleau J, Szyf, M (1995). Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem, 270: 11327-11337.
53. Yang J, Deng C, Hemati N, Hanash S, Richardson BC (1997). Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol, 159: 1301-1309.
54. Deng C, Yang J, Scott J, Hanash S, Richardson BC (1998). Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem, 379: 1113-1120.
55. Bakin AV, Curran T (1999). Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science, 283: 387-390.
56. Butler TL, Kay PH, Jacobsen PF (2000). Hypomethylation of cytosine 5-methyltransferase in human neoplasms. Anticancer Res, 20: 1435-1438.
57. Slack A, Cervoni N, Pinard M, Szyf M (1999). Feedback regulation of DNA methyltransferase gene expression by methylation. Eur J Biochem, 264: 191-199.
58. Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL (2001). Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem, 276: 39508-39511.
59. Peterson EJ, Bogler O, Taylor SM (2003). p53 mediated repression of DNA methyltransferase 1 expression by specific DNA binding. Cancer Res, 63: 6579-6582.
60. Kishikawa S, Murata T, Kimura H, Shiota K, Yokoyama KK (2002). Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. Eur J Biochem, 269: 2961-2970.
61. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y, Yuasa Y (2005). Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3and Sp1 zinc finger proteins. Biochem J, 385: 557-564.
62. Firestone GL, Bjeldanes LF (2003). Indole-3-carbinol and 3,3′-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr, 133: 2448S-2455S.
63. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. (2000). DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet, 25: 338-342.